Compare AUTL & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUTL | VREX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 447.2M |
| IPO Year | 2025 | 2016 |
| Metric | AUTL | VREX |
|---|---|---|
| Price | $1.93 | $18.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.6M | 686.9K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | $10,120,000.00 | ★ $811,000,000.00 |
| Revenue This Year | $80.32 | $5.35 |
| Revenue Next Year | $53.96 | $3.88 |
| P/E Ratio | ★ N/A | $80.61 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $9.09 |
| 52 Week High | $2.58 | $18.63 |
| Indicator | AUTL | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 84.66 |
| Support Level | $1.37 | $12.00 |
| Resistance Level | $1.92 | $18.63 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | -0.05 | -0.24 |
| Stochastic Oscillator | 13.76 | 61.11 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.